This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Cardiovascular System, Other  • Metabolic Diseases  • Cardiovascular Disease/ Myocardial Infarction  • Drug Therapy, Other  • Diabetes Mellitus  • Hypertension  • Alert me on articles by topic

Vivencio Barrios, MD; Carlos Escobar, MD; Rocio Echarri, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the study by Wong et al¹ describing the prevalence, treatment, and control of hypertension among US adults with and without cardiovascular (CV) comorbidities. In this study that included a total of 4646 patients, the overall prevalence of hypertension ranged from 23.1% in those without CV comorbidities to 51.8% to 81.8% in those with CV comorbidities. Interestingly, although hypertension treatment rates for diabetes mellitus, stroke, heart failure, and coronary artery disease were higher (83.4%-89.3%) than the rates for those without these conditions (66.5%) (P < .01), control rates for treatment remained poor (23.2%-49.3%) (P < .001 to P = .048).

The concomitance of CV comorbidities is very frequent in the hypertensive population; however, this common situation is not limited to the US population. Although the Mediterranean population seems to exhibit a low CV risk compared with other Western countries,² . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Inadequate Control of Hypertension in US Adults With Cardiovascular Disease Comorbidities in 2003-2004
Nathan D. Wong, Victor A. Lopez, Gilbert L'Italien, Roland Chen, Sue Ellen J. Kline, and Stanley S. Franklin
Arch Intern Med. 2007;167(22):2431-2436.
ABSTRACT | FULL TEXT